Evidence map›Paper›PMID 38449642›Full record

ReviewHeliyon2024

Review on active components and mechanism of natural product polysaccharides against gastric carcinoma.

Xinze Liu, Kaijing Sun, Xin Jin, Xinmin Wu, Mingjie Xia, Ying Sun, Lin Feng, Guangzhe Li, Xilin Wan, Changbao Chen

Open access · goldAbstract readReview
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Molecular Mechanisms ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xinze LiuJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
Kaijing SunJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
Xin JinKey Laboratory of Molecular Epigenetics of the Ministry of Education (MOE), Northeast Normal University, Changchun, China.
Xinmin WuDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Mingjie XiaDepartment of Gastric and Colorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
Ying SunClinical Laboratory, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Lin FengCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun, 130117, China.
Guangzhe LiCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun, 130117, China.
Xilin WanJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
Changbao ChenJilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, China.
Changchun University of Chinese Medicine · CNJilin University · CNDalian Medical University · CNNortheast Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the malignant tumors with a high occurrence rate worldwide is gastric carcinoma, which is an epithelial malignant tumor emerging from the stomach. Natural product polysaccharides are a kind of natural macromolecular polymers, which have the functions of regulating immunity, anti-oxidation, anti-fatigue, hypoglycemia, etc. Natural polysaccharides have remarkable effectiveness in preventing the onset, according to studies, and development of gastric cancer at both cellular and animal levels. This paper summarizes the inhibitory mechanisms and therapeutic significance of plant polysaccharides, fungi polysaccharides, and algal polysaccharides in natural product polysaccharides on the occurrence and development of gastric cancer in recent years, providing a theoretical basis for the research, development, and medicinal value of polysaccharides.

Indexed as

Active componentsAntineoplasticGastric carcinomaMechanismPolysaccharides

Identifiers

PMID38449642
PMCPMC10915412
OpenAlexW4392302006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.